I7P-MC-DSAD - ClinicalTrials.gov - NCT04493502
I7P-MC-DSAD - ClinicalTrials.gov - NCT04493502
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a diagnosis of HS for at least 6 months
Participants must have HS lesions in at least 2 different anatomic areas
Participants must have inadequate response or intolerance to a 28 day course of oral antibiotics
Participants must have a total count of abscesses and inflammatory nodules greater than or equal to 4
Participants must agree to use a topical antiseptic daily
Participants must agree to stop using topical antibiotics during the study. In certain cases, oral antibiotics will be allowed
Participants must NOT
Participants must not have more than 20 draining fistulae
Participants must not have received any biologic medication (adalimumab, etc.) for the treatment of HS
Participants must not plan to use oral opioids for HS-related pain during the study
Participants must not have uncontrolled depression or suicidal thoughts
Trial Summary
Conditions the trial is for
Hidradenitis Suppurative (Acne Inversa)
What the trial is testing?
LY3041658
Could I receive a Placebo?
no
Enrollment Goal
52
Trial Dates
August 2020 - July 2022
Trial Phase
2
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a diagnosis of HS for at least 6 months
Participants must have HS lesions in at least 2 different anatomic areas
Participants must have inadequate response or intolerance to a 28 day course of oral antibiotics
Participants must have a total count of abscesses and inflammatory nodules greater than or equal to 4
Participants must agree to use a topical antiseptic daily
Participants must agree to stop using topical antibiotics during the study. In certain cases, oral antibiotics will be allowed
Participants must NOT
Participants must not have more than 20 draining fistulae
Participants must not have received any biologic medication (adalimumab, etc.) for the treatment of HS
Participants must not plan to use oral opioids for HS-related pain during the study
Participants must not have uncontrolled depression or suicidal thoughts
Trial Summary
Conditions the trial is for
Hidradenitis Suppurative (Acne Inversa)
What the trial is testing?
LY3041658
Could I receive a Placebo?
no
Enrollment Goal
52
Trial Dates
August 2020 - July 2022
Trial Phase
2
Trial Locations
Hide locations not currently recruiting